Insufficient scRNA-seq data for expression of KLF16 at single-cell level.
Insufficient scRNA-seq data for expression of KLF16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2083.92 | 2634 / 2642 | 100% | 21.22 | 705 / 705 |
skin | 100% | 1285.47 | 1809 / 1809 | 99% | 33.12 | 469 / 472 |
intestine | 99% | 788.09 | 958 / 966 | 100% | 41.68 | 525 / 527 |
bladder | 100% | 684.05 | 21 / 21 | 98% | 29.36 | 496 / 504 |
prostate | 99% | 652.09 | 242 / 245 | 99% | 21.28 | 499 / 502 |
esophagus | 98% | 800.53 | 1418 / 1445 | 100% | 49.15 | 183 / 183 |
lung | 99% | 1009.15 | 575 / 578 | 98% | 25.32 | 1131 / 1155 |
liver | 100% | 751.96 | 225 / 226 | 98% | 17.51 | 397 / 406 |
stomach | 97% | 535.15 | 350 / 359 | 100% | 43.40 | 285 / 286 |
adrenal gland | 100% | 776.11 | 258 / 258 | 97% | 24.44 | 223 / 230 |
kidney | 100% | 817.91 | 89 / 89 | 96% | 16.66 | 868 / 901 |
ovary | 97% | 521.44 | 174 / 180 | 100% | 27.14 | 428 / 430 |
breast | 99% | 580.61 | 453 / 459 | 97% | 21.61 | 1088 / 1118 |
thymus | 97% | 468.50 | 633 / 653 | 98% | 15.41 | 592 / 605 |
uterus | 95% | 613.08 | 161 / 170 | 100% | 29.02 | 458 / 459 |
pancreas | 80% | 326.00 | 262 / 328 | 99% | 32.53 | 177 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 32.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.59 | 29 / 29 |
spleen | 100% | 1429.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.01 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.79 | 1 / 1 |
adipose | 99% | 671.25 | 1193 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 530.06 | 1303 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1175.98 | 901 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 416.51 | 784 / 861 | 0% | 0 | 0 / 0 |
muscle | 29% | 87.49 | 229 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007212 | Biological process | G protein-coupled dopamine receptor signaling pathway |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KLF16 |
Protein name | Krueppel-like factor 16 (Basic transcription element-binding protein 4) (BTE-binding protein 4) (Novel Sp1-like zinc finger transcription factor 2) (Transcription factor BTEB4) (Transcription factor NSLP2) KLF transcription factor 16 |
Synonyms | NSLP2 BTEB4 |
Description | FUNCTION: Transcription factor that binds GC and GT boxes and displaces Sp1 and Sp3 from these sequences. Modulates dopaminergic transmission in the brain (By similarity). . |
Accessions | ENST00000592313.1 Q9BXK1 ENST00000617223.1 A0A087WWX5 ENST00000250916.6 ENST00000541015.5 |